Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2025
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN StudyAlfredo Caturano, Raffaele Galiero, Vittorio Simeon, et al.
American Journal of Preventive Cardiology|December 11, 2025
Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation: The role of TSP-1Celestino Sardu, Giovanni Francesco Nicoletti, Maria Consiglia Trotta, et al.
Pharmacological Research|June 13, 2022
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical besideCelestino Sardu, Massimo Massetti, Lucia Scisciola, et al.
Journal of Cellular Physiology|July 12, 2019
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patientsNunzia D'Onofrio, Celestino Sardu, Pasquale Paolisso, et al.
BMC Medicine|February 24, 2023
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetesRaffaele Marfella, Celestino Sardu, Nunzia D'Onofrio, et al.
Nature Clinical Practice. Cardiovascular Medicine|April 17, 2008
Therapeutic targeting of the stem cell niche in experimental hindlimb ischemiaClaudio Napoli, Sharon William-Ignarro, Russell Byrns, et al.
Cardiovascular Diabetology|August 5, 2022
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic heartsRaffaele Marfella, Nunzia D'Onofrio, Gelsomina Mansueto, et al.
Molecular Metabolism|September 9, 2021
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatmentNunzia D'Onofrio, Celestino Sardu, Maria Consiglia Trotta, et al.
Critical Care (London, England)|June 25, 2021
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarctionRaffaele Marfella, Pasquale Paolisso, Celestino Sardu, et al.
Diabetes Research and Clinical Practice|September 5, 2025
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational studyCelestino Sardu, Ludovica Vittoria Marfella, Luca Rinaldi, et al.
Pageof 14